Skip to main content
Top
Published in: BMC Infectious Diseases 1/2018

Open Access 01-12-2018 | Research article

Addressing knowledge gaps and prevention for tuberculosis-infected Indian adults: a vital part of elimination

Authors: Andrea DeLuca, Gauri Dhumal, Mandar Paradkar, Nishi Suryavanshi, Vidya Mave, Rewa Kohli, Shri Vijay Bala Yogendra Shivakumar, Vidula Hulyolkar, Archana Gaikwad, Ashwini Nangude, Geeta Pardeshi, Dileep Kadam, Amita Gupta

Published in: BMC Infectious Diseases | Issue 1/2018

Login to get access

Abstract

Background

India plans to eliminate tuberculosis (TB) by 2025, and has identified screening and prevention as key activities. Household contacts (HHCs) of index TB cases are a high-risk population that would benefit from rapid implementation of these strategies. However, best practices for TB prevention and knowledge gaps among HHCs have not been studied. We evaluated TB knowledge and understanding of prevention among tuberculin skin-test (TST) positive HHCs. While extensive information is available in other high-burden settings regarding TB knowledge gaps, identifying how Indian adult contacts view their transmission risk and prevention options may inform novel screening algorithms and education efforts that will be part of the new elimination plan.

Methods

We approached adult HHC to administer a questionnaire on TB knowledge and understanding of infection. Over 1 year, 100 HHC were enrolled at a tertiary hospital in Pune, India.

Results

The study population was 61% (n = 61) female, with a mean age of 36.6 years (range 18–67, SD = 12). Education levels were high, with 78 (78%) having at least a high school education, and 23 (24%) had at least some college education. Four (4%) of our participants were HIV-infected.
General TB knowledge among HHC was low, with a majority of participants believing that you can get TB from sharing dishes (70%) or touching something that has been coughed on (52%). Understanding of infection was also low, with 42% believing that being skin-test positive means you have disease. To assess readiness for preventive therapy, we asked participants whether they are at a higher risk of progressing to active disease because of their LTBI status. Fifty-four (55%) felt that they are at higher risk. Only 8% had heard of preventive therapy.

Conclusion

Our TB knowledge survey among HHCs with evidence of recent exposure found that knowledge is poor and families are confused about transmission in the household. It is imperative that the Indian program develop tools and incentives that can be used to educate TB cases and their families on what infected HHCs can do to prevent disease, including preventive therapy.
Literature
2.
go back to reference Program RNTC: National Strategic Plan for tuberculosis elimination 2017–2025. In. New Delhi, India: Central TB Division; 2017. Program RNTC: National Strategic Plan for tuberculosis elimination 2017–2025. In. New Delhi, India: Central TB Division; 2017.
3.
go back to reference Comstock GW, Ferebee SH, Hammes LM. A controlled trial of community-wide isoniazid prophylaxis in Alaska. Am Rev Respir Dis. 1967;95(6):935–43.PubMed Comstock GW, Ferebee SH, Hammes LM. A controlled trial of community-wide isoniazid prophylaxis in Alaska. Am Rev Respir Dis. 1967;95(6):935–43.PubMed
4.
go back to reference Comstock GW, Baum C, Snider DE Jr. Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies. Am Rev Respir Dis. 1979;119(5):827–30.PubMed Comstock GW, Baum C, Snider DE Jr. Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies. Am Rev Respir Dis. 1979;119(5):827–30.PubMed
5.
go back to reference Ayles H, Muyoyeta M, Du Toit E, Schaap A, Floyd S, Simwinga M, Shanaube K, Chishinga N, Bond V, Dunbar R, et al. Effect of household and community interventions on the burden of tuberculosis in southern Africa: the ZAMSTAR community-randomised trial. Lancet. 2013;382(9899):1183–94.CrossRefPubMed Ayles H, Muyoyeta M, Du Toit E, Schaap A, Floyd S, Simwinga M, Shanaube K, Chishinga N, Bond V, Dunbar R, et al. Effect of household and community interventions on the burden of tuberculosis in southern Africa: the ZAMSTAR community-randomised trial. Lancet. 2013;382(9899):1183–94.CrossRefPubMed
6.
go back to reference Rangaka MX, Cavalcante SC, Marais BJ, Thim S, Martinson NA, Swaminathan S, Chaisson RE. Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection. Lancet. 2015;386(10010):2344–53.CrossRefPubMedPubMedCentral Rangaka MX, Cavalcante SC, Marais BJ, Thim S, Martinson NA, Swaminathan S, Chaisson RE. Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection. Lancet. 2015;386(10010):2344–53.CrossRefPubMedPubMedCentral
8.
go back to reference Organization WH, editor. Global tuberculosis report 2016. Geneva: Organization WH; 2016. Organization WH, editor. Global tuberculosis report 2016. Geneva: Organization WH; 2016.
9.
go back to reference Pai M, Bhaumik S, Bhuyan SS. India's plan to eliminate tuberculosis by 2025: converting rhetoric into reality. BMJ Glob Health. 2016;2(2):e000326.CrossRefPubMed Pai M, Bhaumik S, Bhuyan SS. India's plan to eliminate tuberculosis by 2025: converting rhetoric into reality. BMJ Glob Health. 2016;2(2):e000326.CrossRefPubMed
10.
go back to reference Pai M, Correa N, Mistry N, Jha P. Reducing global tuberculosis deaths-time for India to step up. Lancet (London, England). 2017;389(10075):1174–6.CrossRef Pai M, Correa N, Mistry N, Jha P. Reducing global tuberculosis deaths-time for India to step up. Lancet (London, England). 2017;389(10075):1174–6.CrossRef
11.
go back to reference Samandari T, Agizew TB, Nyirenda S, Tedla Z, Sibanda T, Shang N, Mosimaneotsile B, Motsamai OI, Bozeman L, Davis MK, et al. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. Lancet. 2011;377(9777):1588–98.CrossRefPubMed Samandari T, Agizew TB, Nyirenda S, Tedla Z, Sibanda T, Shang N, Mosimaneotsile B, Motsamai OI, Bozeman L, Davis MK, et al. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. Lancet. 2011;377(9777):1588–98.CrossRefPubMed
13.
go back to reference Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bulletin of World Health Organization 1982, 60. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bulletin of World Health Organization 1982, 60.
14.
go back to reference Whalen CC, Johnson JL, Okwera A, Hom DL, Huebner R, Mugyenyi P, Mugerwa RD, Ellner JJ. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University research collaboration. N Engl J Med. 1997;337(12):801–8.CrossRefPubMed Whalen CC, Johnson JL, Okwera A, Hom DL, Huebner R, Mugyenyi P, Mugerwa RD, Ellner JJ. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University research collaboration. N Engl J Med. 1997;337(12):801–8.CrossRefPubMed
15.
go back to reference Ayieko J, Abuogi L, Simchowitz B, Bukusi EA, Smith AH, Reingold A. Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta-analysis. BMC Infect Dis. 2014;14:91.CrossRefPubMedPubMedCentral Ayieko J, Abuogi L, Simchowitz B, Bukusi EA, Smith AH, Reingold A. Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta-analysis. BMC Infect Dis. 2014;14:91.CrossRefPubMedPubMedCentral
16.
go back to reference Banu Rekha VV, Jagarajamma K, Wares F, Chandrasekaran V, Swaminathan S. Contact screening and chemoprophylaxis in India's revised tuberculosis control Programme: a situational analysis. Int J Tuberc Lung Dis. 2009;13(12):1507–12.PubMed Banu Rekha VV, Jagarajamma K, Wares F, Chandrasekaran V, Swaminathan S. Contact screening and chemoprophylaxis in India's revised tuberculosis control Programme: a situational analysis. Int J Tuberc Lung Dis. 2009;13(12):1507–12.PubMed
17.
go back to reference Pho MT, Swaminathan S, Kumarasamy N, Losina E, Ponnuraja C, Uhler LM, Scott CA, Mayer KH, Freedberg KA, Walensky RP. The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis. PLoS One. 2012;7(4):e36001.CrossRefPubMedPubMedCentral Pho MT, Swaminathan S, Kumarasamy N, Losina E, Ponnuraja C, Uhler LM, Scott CA, Mayer KH, Freedberg KA, Walensky RP. The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis. PLoS One. 2012;7(4):e36001.CrossRefPubMedPubMedCentral
18.
go back to reference Rekha B, Jagarajamma K, Chandrasekaran V, Wares F, Sivanandham R, Swaminathan S. Improving screening and chemoprophylaxis among child contacts in India's RNTCP: a pilot study. Int J Tuberc Lung Dis. 2013;17(2):163–8.CrossRefPubMed Rekha B, Jagarajamma K, Chandrasekaran V, Wares F, Sivanandham R, Swaminathan S. Improving screening and chemoprophylaxis among child contacts in India's RNTCP: a pilot study. Int J Tuberc Lung Dis. 2013;17(2):163–8.CrossRefPubMed
19.
go back to reference Swaminathan S, Menon PA, Gopalan N, Perumal V, Santhanakrishnan RK, Ramachandran R, Chinnaiyan P, Iliayas S, Chandrasekaran P, Navaneethapandian PD, et al. Efficacy of a six-month versus a 36-month regimen for prevention of tuberculosis in HIV-infected persons in India: a randomized clinical trial. PLoS One. 2012;7(12):e47400.CrossRefPubMedPubMedCentral Swaminathan S, Menon PA, Gopalan N, Perumal V, Santhanakrishnan RK, Ramachandran R, Chinnaiyan P, Iliayas S, Chandrasekaran P, Navaneethapandian PD, et al. Efficacy of a six-month versus a 36-month regimen for prevention of tuberculosis in HIV-infected persons in India: a randomized clinical trial. PLoS One. 2012;7(12):e47400.CrossRefPubMedPubMedCentral
20.
go back to reference Narain R, Mayurnath S, Rao MS, Murthy SS. Feasibility of a chemoprophylaxis trial in India against tuberculosis. A pilot study. Bull World Health Organ. 1970;43(1):41–52.PubMedPubMedCentral Narain R, Mayurnath S, Rao MS, Murthy SS. Feasibility of a chemoprophylaxis trial in India against tuberculosis. A pilot study. Bull World Health Organ. 1970;43(1):41–52.PubMedPubMedCentral
21.
go back to reference Singh AR, Kharate A, Bhat P, Kokane AM, Bali S, Sahu S, Verma M, Nagar M, Kumar AM. Isoniazid preventive therapy among children living with tuberculosis patients: is it working? A mixed-method study from Bhopal, India. J Trop Pediatr. 2017;63(4):274–85.PubMed Singh AR, Kharate A, Bhat P, Kokane AM, Bali S, Sahu S, Verma M, Nagar M, Kumar AM. Isoniazid preventive therapy among children living with tuberculosis patients: is it working? A mixed-method study from Bhopal, India. J Trop Pediatr. 2017;63(4):274–85.PubMed
22.
go back to reference Shivaramakrishna HR, Frederick A, Shazia A, Murali L, Satyanarayana S, Nair SA, Kumar AM, Moonan PK. Isoniazid preventive treatment in children in two districts of South India: does practice follow policy? Int J Tuberc Lung Dis. 2014;18(8):919–24.CrossRefPubMedPubMedCentral Shivaramakrishna HR, Frederick A, Shazia A, Murali L, Satyanarayana S, Nair SA, Kumar AM, Moonan PK. Isoniazid preventive treatment in children in two districts of South India: does practice follow policy? Int J Tuberc Lung Dis. 2014;18(8):919–24.CrossRefPubMedPubMedCentral
23.
go back to reference Central TB Devision MoHaFW, Goverment of India. National Guidelines on diagnosis and treatment of Pediatric Tuberculosis, Revised National Tuberculosis Control Programme; 2012. p. 1–16. Central TB Devision MoHaFW, Goverment of India. National Guidelines on diagnosis and treatment of Pediatric Tuberculosis, Revised National Tuberculosis Control Programme; 2012. p. 1–16.
24.
go back to reference Gupte A, Padmapriyadarsini C, Mave V, Kadam D, Suryavanshi N, Shivakumar SV, Kohli R, Gupte N, Thiruvengadam K, Kagal A, et al. Cohort for tuberculosis research by the indo-US medical partnership (CTRIUMPH): protocol for a multicentric prospective observational study. BMJ Open. 2016;6(2):e010542.CrossRefPubMedPubMedCentral Gupte A, Padmapriyadarsini C, Mave V, Kadam D, Suryavanshi N, Shivakumar SV, Kohli R, Gupte N, Thiruvengadam K, Kagal A, et al. Cohort for tuberculosis research by the indo-US medical partnership (CTRIUMPH): protocol for a multicentric prospective observational study. BMJ Open. 2016;6(2):e010542.CrossRefPubMedPubMedCentral
25.
go back to reference Sinhal K: Soon, ban on blood tests to detect TB. In: Times of India. 2012. Sinhal K: Soon, ban on blood tests to detect TB. In: Times of India. 2012.
27.
go back to reference Butcher K, Biggs BA, Leder K, Lemoh C, O'Brien D, Marshall C. Understanding of latent tuberculosis, its treatment and treatment side effects in immigrant and refugee patients. BMC Res Notes. 2013;6:342.CrossRefPubMedPubMedCentral Butcher K, Biggs BA, Leder K, Lemoh C, O'Brien D, Marshall C. Understanding of latent tuberculosis, its treatment and treatment side effects in immigrant and refugee patients. BMC Res Notes. 2013;6:342.CrossRefPubMedPubMedCentral
28.
go back to reference Bond V, Floyd S, Fenty J, Schaap A, Godfrey-Faussett P, Claassens M, Shanaube K, Ayles H, Hargreaves JR. Secondary analysis of tuberculosis stigma data from a cluster randomised trial in Zambia and South Africa (ZAMSTAR). Int J Tuberc Lung Dis. 2017;21(11):49–59.CrossRefPubMed Bond V, Floyd S, Fenty J, Schaap A, Godfrey-Faussett P, Claassens M, Shanaube K, Ayles H, Hargreaves JR. Secondary analysis of tuberculosis stigma data from a cluster randomised trial in Zambia and South Africa (ZAMSTAR). Int J Tuberc Lung Dis. 2017;21(11):49–59.CrossRefPubMed
29.
go back to reference Miller C, Huston J, Samu L, Mfinanga S, Hopewell P, Fair E. It makes the patient's spirit weaker': tuberculosis stigma and gender interaction in Dar es salaam, Tanzania. Int J Tuberc Lung Dis. 2017;21(11):42–8.CrossRefPubMed Miller C, Huston J, Samu L, Mfinanga S, Hopewell P, Fair E. It makes the patient's spirit weaker': tuberculosis stigma and gender interaction in Dar es salaam, Tanzania. Int J Tuberc Lung Dis. 2017;21(11):42–8.CrossRefPubMed
30.
go back to reference Mathew A, Takalkar A. Living with tuberculosis: the myths and the stigma from the Indian perspective. CID. 2007;45(9):1247.CrossRef Mathew A, Takalkar A. Living with tuberculosis: the myths and the stigma from the Indian perspective. CID. 2007;45(9):1247.CrossRef
31.
go back to reference Sommerland N, Wouters E, Mitchell EMH, Ngicho M, Redwood L, Masquillier C, van Hoorn R, van den Hof S, Van Rie A. Evidence-based interventions to reduce tuberculosis stigma: a systematic review. Int J Tuberc Lung Dis. 2017;21(11):81–6.CrossRefPubMed Sommerland N, Wouters E, Mitchell EMH, Ngicho M, Redwood L, Masquillier C, van Hoorn R, van den Hof S, Van Rie A. Evidence-based interventions to reduce tuberculosis stigma: a systematic review. Int J Tuberc Lung Dis. 2017;21(11):81–6.CrossRefPubMed
32.
go back to reference Jacobson KB, Niccolai L, Mtungwa N, Moll AP, Shenoi SV. “It’s about my life”: facilitators of and barriers to isoniazid preventive therapy completion among people living with HIV in rural South Africa. AIDS Care. 2017;29(7):936–42.CrossRefPubMed Jacobson KB, Niccolai L, Mtungwa N, Moll AP, Shenoi SV. “It’s about my life”: facilitators of and barriers to isoniazid preventive therapy completion among people living with HIV in rural South Africa. AIDS Care. 2017;29(7):936–42.CrossRefPubMed
33.
go back to reference Zaeh S, Kempker R, Stenehjem E, Blumberg HM, Temesgen O, Ofotokun I, Tenna A. Improving tuberculosis screening and isoniazid preventive therapy in an HIV clinic in Addis Ababa, Ethiopia. Int J Tuberc Lung Dis. 2013;17(11):1396–401.CrossRefPubMedPubMedCentral Zaeh S, Kempker R, Stenehjem E, Blumberg HM, Temesgen O, Ofotokun I, Tenna A. Improving tuberculosis screening and isoniazid preventive therapy in an HIV clinic in Addis Ababa, Ethiopia. Int J Tuberc Lung Dis. 2013;17(11):1396–401.CrossRefPubMedPubMedCentral
34.
go back to reference Skinner D, Hesseling AC, Francis C, Mandalakas AM. It’s hard work, but it's worth it: the task of keeping children adherent to isoniazid preventive therapy. Public Health Action. 2013;3(3):191–8.CrossRefPubMedPubMedCentral Skinner D, Hesseling AC, Francis C, Mandalakas AM. It’s hard work, but it's worth it: the task of keeping children adherent to isoniazid preventive therapy. Public Health Action. 2013;3(3):191–8.CrossRefPubMedPubMedCentral
35.
go back to reference Rutherford ME, Ruslami R, Maharani W, Yulita I, Lovell S, Van Crevel R, Alisjahbana B, Hill PC. Adherence to isoniazid preventive therapy in Indonesian children: a quantitative and qualitative investigation. BMC Research Notes. 2012;5(1):1–7.CrossRef Rutherford ME, Ruslami R, Maharani W, Yulita I, Lovell S, Van Crevel R, Alisjahbana B, Hill PC. Adherence to isoniazid preventive therapy in Indonesian children: a quantitative and qualitative investigation. BMC Research Notes. 2012;5(1):1–7.CrossRef
36.
go back to reference Cox V, de Azevedo V, Stinson K, Wilkinson L, Rangaka M, Boyles TH. Diagnostic accuracy of tuberculin skin test self-reading by HIV patients in a low-resource setting. Int J Tuberc Lung Dis. 2015;19(11):1300–4.CrossRefPubMed Cox V, de Azevedo V, Stinson K, Wilkinson L, Rangaka M, Boyles TH. Diagnostic accuracy of tuberculin skin test self-reading by HIV patients in a low-resource setting. Int J Tuberc Lung Dis. 2015;19(11):1300–4.CrossRefPubMed
37.
go back to reference M'Imunya JM, Kredo T, Volmink J. Patient education and counselling for promoting adherence to treatment for tuberculosis. Cochrane Database Syst Rev. 2012;5:Cd006591. M'Imunya JM, Kredo T, Volmink J. Patient education and counselling for promoting adherence to treatment for tuberculosis. Cochrane Database Syst Rev. 2012;5:Cd006591.
Metadata
Title
Addressing knowledge gaps and prevention for tuberculosis-infected Indian adults: a vital part of elimination
Authors
Andrea DeLuca
Gauri Dhumal
Mandar Paradkar
Nishi Suryavanshi
Vidya Mave
Rewa Kohli
Shri Vijay Bala Yogendra Shivakumar
Vidula Hulyolkar
Archana Gaikwad
Ashwini Nangude
Geeta Pardeshi
Dileep Kadam
Amita Gupta
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-3116-7

Other articles of this Issue 1/2018

BMC Infectious Diseases 1/2018 Go to the issue